Onebiopharma
Boston, US · Founded 2018 · Delaware corporation
Founders & leadership
MW
Michael WyandNamed on SEC filing
AM
Amit MunshiNamed on SEC filing
EB
Elon BomsNamed on SEC filing
AW
Andrew WingateNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2019
▶$3MraisedMay 2019 · 2 investors · Other Health CareRule 506(b)
▶$3MraisedMay 2019 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael WyandExecutive Officer, Director
- Amit MunshiDirector
- Elon BomsDirector
- Andrew WingateDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Onebiopharma raised?
- Onebiopharma has disclosed $3M raised across 1 round.
- Where is Onebiopharma headquartered?
- Onebiopharma is headquartered in Boston, US.